The 11th Innate Killer Summit is the only industry event in the world focused solely on advancing NK and innate immune cell therapies, and this year in particular feels like a real turning point for the field.
Inside the event guide, you’ll get a look at how leading biotechs and academic teams are tackling some of the biggest hurdles in NK therapy, like improving long-term persistence, targeting solid tumors more effectively, scaling up manufacturing, and standing out in a competitive clinical space.
With insights from NKILT, Senti Bio, MD Anderson Cancer Center, and many others, this summit brings together the entire NK community at a time when collaboration and clarity are more important than ever.
Expect 22+ expert speakers, 8+ sessions featuring new clinical data, a CEO panel, hands-on workshops, and plenty of chances to connect with the people shaping what’s next.
If you’re working on the future of innate cell therapies, this is one event you’ll want to be part of.
About Hanson Wade Group - 11th Innate Killer Summit
Driving Long Term Persistence, Clinical Efficacy & Scalability Across Autoimmunity & Oncology, to Spearhead an Investment Revival in NK Therapies for Patients in Need
The 11th Innate Killer Summit continues its legacy as the world’s leading industry meeting dedicated exclusively to advancing NK and innate immune cell therapies.
This year, the summit unites pioneering biotechs, including NKILT, Senti Bio, NKore, and leaders from the MD Anderson Rizvani Lab, alongside translational scientists and platform innovators to showcase breakthrough progress in engineering, manufacturing, persistence, tumor targeting, and clinical translation.
As the NK space becomes increasingly competitive and the path to differentiation narrows, this summit stands firmly alongside the global NK community, providing the clarity, collaboration, and momentum needed to keep innovation moving forward.
With in-depth scientific content, real-world clinical insights across six clinical data updates, and unparalleled access to the full NK ecosystem, the 11th Innate Killer Summit remains the go-to meeting for those shaping the future of innate cell therapy. Now is the moment to align, connect, and act, as breakthroughs accelerate and the field enters a defining year for next-generation NK cell therapies.
Download the Event Guide
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.